H.R. 6130 · 119th Congress

Adds Medicare coverage of blood tests to screen for early Alzheimer's disease

Official title: ASAP Act1

Never got a floor voteMedicare coverage of new tests and services

§1What it does

Why this matters: A plain-English description of the bill as it was voted on, written by us from the official summary and text.

Drafted by AI from the public sources cited. Each sentence links to its source.

This bill would add Medicare coverage for blood tests that screen for the early stages of Alzheimer's disease or related dementias.2,3 Covered tests would include genomic sequencing blood tests, or other equivalent tests, approved by the Food and Drug Administration.2,3

§2Status

StatusLatest action, September 16, 2026: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.1
IntroducedNovember 19, 2025
SponsorRep. Buchanan, Vern [R-FL-16]
Cosponsors231 cosponsors (137 Democratic, 93 Republican, 1 independent)
Official recordH.R. 6130 on Congress.gov

§3It never got a vote

Why this matters: This bill had wide support from both parties, but it never reached the House or Senate floor, so no member of Congress was ever recorded voting for or against it.

Latest action, September 16, 2026: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.1 How bills die without a vote.

2026 candidates who sponsored or cosponsored it (206)